Intelligent Bio Solutions Inc. — Revenue by Fiscal Year
7 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/9f74e5d9-4f42-4e4b-ac83-546dd191d4fe/serie/revenue
| Fiscal year | Revenue | Period | Evidence |
|---|---|---|---|
| FY 2026 | $4.2M | 2025-07-01 – 2026-06-30 | evidence 0001493152-26-039136 |
| FY 2025 | $3.1M | 2024-07-01 – 2025-06-30 | evidence 0001641172-25-024279 |
| FY 2024 | $3.1M | 2023-07-01 – 2024-06-30 | evidence 0001493152-24-036953 |
| FY 2023 | $1.3M | 2022-07-01 – 2023-06-30 | evidence 0001493152-23-029992 |
| FY 2022 | $437.1k | 2021-07-01 – 2022-06-30 | evidence 0001493152-22-026526 |
| FY 2021 | $2.0M | 2020-07-01 – 2021-06-30 | evidence 0001493152-22-026526 |
| FY 2020 | $188.7k | 2019-07-01 – 2020-06-30 | evidence 0001493152-21-022851 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
Intelligent Bio Solutions Inc. — all facts · Net Income · Operating Income